Biologics Market in Brazil
Biologics Market in Brazil
Regulations and Patent Expirations Challenge Brazilian Laboratories
RELEASE DATE
02-Mar-2012
02-Mar-2012
REGION
Latin America
Latin America
Research Code: N8FD-01-00-00-00
SKU: HC02185-LA-MR_07840
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC02185-LA-MR_07840
Description
This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key market drivers and restraints in addition to breaking down the current and forecasted competitive scenario. The base year of the study is 2010, and the forecast period is 2011 to 2017.
Table of Contents
Biologics Market
- Biologics
Popular Topics
This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key market drivers and restraints in addition to breaking down the current and forecasted competitive scenario. The base year of the study is 2010, and the forecast period is 2011 to 2017.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N8FD-01-00-00-00 |
Is Prebook | No |